January 13, 2021
2 min watch
Save
Racial disparities, need for a push in novel target therapies for multiple myeloma
Healio spoke with Ajay K. Nooka, MD, MPH, FACP, associate professor of hematology and medical oncology at Emory School of Medicine, about the need to reach underserved communities, identification of additional novel targets like GPRC5D and improvement in combination treatments with immunotherapies.
Watch the video for more on unmet needs in multiple myeloma.
Published by:
Sources/Disclosures
Collapse
Disclosures:
Nooka reports grant/research support from or advisory committee, review panel or board membership with Amgen, Bristol Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Karyopharm Therapeutics, Oncopeptides, Sanofi and Takeda.
Read more about